Nuzenio

Neoadjuvant Mss Colon

Neoadjuvant Mss Colon news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 8 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Agenus Inc. (AGEN) grants director 50,000 stock options at $7.78 - Stock TitanStock Titan · Fri, 07 Aug 2026 18:17:08 GMT Agenus (AGEN) awards 200,000 stock options to executive chair Jennifer Buell - Stock TitanStock Titan · Fri, 07 Aug 2026 18:08:08 GMT Agenus Advances BOT+BAL in Neoadjuvant MSS Colon Cancer Through Phase 3 ROBBIN Trial - OncodailyOncodaily · Fri, 07 Aug 2026 08:38:45 GMT Agenus Reports Second Quarter 2026 Results and Advances Phase 3 ROBBIN Trial of BOT+BAL in Neoadjuvant MSS Colon Cancer - BioSpaceBioSpace · Thu, 06 Aug 2026 12:39:14 GMT Agenus advances Phase 3 ROBBIN trial of botensilimab-balstilimab in neoadjuvant MSS colon cancer - BitgetBitget · Thu, 06 Aug 2026 03:53:29 GMT Agenus posts corporate presentation spotlighting botensilimab-balstilimab neoadjuvant strategy in MSS colon cancer - BitgetBitget · Thu, 30 Jul 2026 07:00:00 GMT Agenus plans August webcast on BOT+BAL colon cancer trial - Stock TitanStock Titan · Tue, 28 Jul 2026 07:00:00 GMT AGENUS INC SEC Filing (Jul 28, 2026) - Stock TitanStock Titan · Tue, 28 Jul 2026 07:00:00 GMT

Timeline

Fri, 07 Aug 2026 18:17:08 GMTAgenus Inc. (AGEN) grants director 50,000 stock options at $7.78 - Stock Titan

Fri, 07 Aug 2026 18:08:08 GMTAgenus (AGEN) awards 200,000 stock options to executive chair Jennifer Buell - Stock Titan

Fri, 07 Aug 2026 08:38:45 GMTAgenus Advances BOT+BAL in Neoadjuvant MSS Colon Cancer Through Phase 3 ROBBIN Trial - Oncodaily

Thu, 06 Aug 2026 12:39:14 GMTAgenus Reports Second Quarter 2026 Results and Advances Phase 3 ROBBIN Trial of BOT+BAL in Neoadjuvant MSS Colon Cancer - BioSpace

Thu, 06 Aug 2026 03:53:29 GMTAgenus advances Phase 3 ROBBIN trial of botensilimab-balstilimab in neoadjuvant MSS colon cancer - Bitget

Thu, 30 Jul 2026 07:00:00 GMTAgenus posts corporate presentation spotlighting botensilimab-balstilimab neoadjuvant strategy in MSS colon cancer - Bitget

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.

Connected entities

BAL6 live mentions BOT5 live mentions AGEN4 live mentions Agenus4 live mentions MSS4 live mentions Stock Titan Agenus3 live mentions Stock Titan Stock3 live mentions Titan3 live mentions ROBBIN Trial3 live mentions Cancer Through Phase2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Neoadjuvant Mss Colon.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.